期刊
CANCER CELL
卷 21, 期 1, 页码 105-120出版社
CELL PRESS
DOI: 10.1016/j.ccr.2011.12.006
关键词
-
资金
- National Cancer Institute [CA109405, CA142674]
- Cancer Center [CA16672]
- China Medical University and Hospital
- MD Anderson Cancer Center
Constitutive Kras and NF-kappa B activation is identified as signature alterations in pancreatic ductal adenocarcinoma (PDAC). However, how NF-kappa B is activated in PDAC is not yet understood. Here, we report that pancreas-targeted IKK2/beta inactivation inhibited NF-kappa B activation and PDAC development in KraS(G12D) and Kras(G12D);Ink4a/Arf(F/F) mice, demonstrating a mechanistic link between IKK2/beta and Kras(G12D) in PDAC inception. Our findings reveal that Kras(G12D)-activated AP-1 induces IL-1 alpha, which, in turn, activates NF-kappa B and its target genes IL-1 alpha and p62, to initiate IL-1 alpha/p62 feedforward loops for inducing and sustaining NF-kappa B activity. Furthermore, IL-1 alpha overexpression correlates with Kras mutation, NF-kappa B activity, and poor survival in PDAC patients. Therefore, our findings demonstrate the mechanism by which IKK2/beta/NF-kappa B is activated by KraS(G12D) through dual feedforward loops of IL-1 alpha/p62.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据